SPIA
MNTA

Steward Partners Investment Advisory’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Steward Partners Investment Advisory’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-144
Closed -$2K – 2381
2017
Q4 		$2K Hold
144
– – ﹤0.01% 1743
2017
Q3 		$2K Hold
144
– – ﹤0.01% 1550
2017
Q2 		$2K Hold
144
– – ﹤0.01% 1471
2017
Q1 		$1K Buy
+144
New +$2.25K ﹤0.01% 1466

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Steward Partners Investment Advisory's MNTA Position: Q1 2018 in Review

Steward Partners Investment Advisory sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2018, closing a stake of 144 shares — an estimated $2K sold.

Steward Partners Investment Advisory first reported a position in MNTA in Q1 2017 and held it in 4 quarters. The position peaked at $2K in Q4 2017. 163 funds tracked by Wall St. Rank hold MNTA as of Q1 2018.

  • Steward Partners Investment Advisory reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 144 Momenta Pharmaceuticals, Inc. shares in Q1 2018, an estimated $2K.
  • Steward Partners Investment Advisory first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • Steward Partners Investment Advisory's Momenta Pharmaceuticals, Inc. position peaked at $2K in Q4 2017.
  • 163 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2018, filed 20 Apr 2018.